Niloufar Kavian

2.8k total citations
46 papers, 1.8k citations indexed

About

Niloufar Kavian is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Niloufar Kavian has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 19 papers in Pathology and Forensic Medicine and 12 papers in Molecular Biology. Recurrent topics in Niloufar Kavian's work include Systemic Sclerosis and Related Diseases (17 papers), Mast cells and histamine (11 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Niloufar Kavian is often cited by papers focused on Systemic Sclerosis and Related Diseases (17 papers), Mast cells and histamine (11 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). Niloufar Kavian collaborates with scholars based in France, Hong Kong and United States. Niloufar Kavian's co-authors include Frédéric Batteux, Carole Nicco, Christiane Chéreau, Bernard Weill, Amélie Servettaz, Philippe Guilpain, Wioleta Marut, Nathaniel Edward Bennett Saidu, Claire Goulvestre and Asmaa Hachim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Immunology.

In The Last Decade

Niloufar Kavian

46 papers receiving 1.8k citations

Peers

Niloufar Kavian

IMMUN

PFM

PRM

Amélie Servettaz France

George D. Kalliolias United States

Xinhua Yu Germany

Shadi Swaidani United States

Robert B. Lorsbach United States

David M. Essayan United States

Samuel Rotman Switzerland

Arturo Genovese Italy

Paolo Fadda United States

Eva Martínez‐Cáceres Spain

Amélie Servettaz France

Niloufar Kavian

426 ×0.6

497 ×1.0

IMMUN

632 ×1.4

PFM

73 ×0.2

427 ×1.7

PRM

Citations per year, relative to Niloufar Kavian Niloufar Kavian (= 1×) peers Amélie Servettaz

Countries citing papers authored by Niloufar Kavian

Since Specialization

Citations

This map shows the geographic impact of Niloufar Kavian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niloufar Kavian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niloufar Kavian more than expected).

Fields of papers citing papers by Niloufar Kavian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Niloufar Kavian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niloufar Kavian. The network helps show where Niloufar Kavian may publish in the future.

Co-authorship network of co-authors of Niloufar Kavian

This figure shows the co-authorship network connecting the top 25 collaborators of Niloufar Kavian. A scholar is included among the top collaborators of Niloufar Kavian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Niloufar Kavian. Niloufar Kavian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Samuel M. S., Kathy Leung, Cheuk Kwong Lee, et al.. (2023). Serological assays for differentiating natural COVID-19 infection from vaccine induced immunity. Journal of Clinical Virology. 170. 105621–105621. 3 indexed citations

Hachim, Asmaa, Haogao Gu, Otared Kavian, et al.. (2022). SARS-CoV-2 accessory proteins reveal distinct serological signatures in children. Nature Communications. 13(1). 2951–2951. 17 indexed citations

Hachim, Asmaa, Niloufar Kavian, & Sophie A. Valkenburg. (2021). Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets. Current Opinion in Virology. 50. 139–146. 5 indexed citations

Kavian, Niloufar, Asmaa Hachim, Carolyn A. Cohen, et al.. (2020). Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adults. Clinical & Translational Immunology. 9(2). e1107–e1107. 16 indexed citations

Kavian, Niloufar, Asmaa Hachim, Leo L. M. Poon, & Sophie A. Valkenburg. (2020). Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection. Vaccine. 38(37). 5885–5890. 8 indexed citations

Kavian, Niloufar, Sandrine Chouzenoux, Carole Nicco, et al.. (2019). Role of thyroid dysimmunity and thyroid hormones in endometriosis. Proceedings of the National Academy of Sciences. 116(24). 11894–11899. 27 indexed citations

Jeljeli, Mohamed, Luiza Gama Coelho Riccio, Ludivine Doridot, et al.. (2019). Trained immunity modulates inflammation-induced fibrosis. Nature Communications. 10(1). 5670–5670. 103 indexed citations

Kavian, Niloufar, Mohamed Jeljeli, Nathaniel Edward Bennett Saidu, et al.. (2018). The Nrf2-Antioxidant Response Element Signaling Pathway Controls Fibrosis and Autoimmunity in Scleroderma. Frontiers in Immunology. 9. 1896–1896. 79 indexed citations

Cerles, Olivier, Évelyne Benoit, Christiane Chéreau, et al.. (2016). Niclosamide Inhibits Oxaliplatin Neurotoxicity while Improving Colorectal Cancer Therapeutic Response. Molecular Cancer Therapeutics. 16(2). 300–311. 37 indexed citations

10.

Kavian, Niloufar, Wioleta Marut, Amélie Servettaz, et al.. (2016). Imbalance of the Vanin-1 Pathway in Systemic Sclerosis. The Journal of Immunology. 197(8). 3326–3335. 26 indexed citations

11.

Morin, Florence, Niloufar Kavian, Carole Nicco, et al.. (2016). Improvement of Sclerodermatous Graft-Versus-Host Disease in Mice by Niclosamide. Journal of Investigative Dermatology. 136(11). 2158–2167. 14 indexed citations

12.

Morin, Florence, Niloufar Kavian, & Frédéric Batteux. (2015). Animal Models of Systemic Sclerosis. Current Pharmaceutical Design. 21(18). 2365–2379. 12 indexed citations

13.

Kavian, Niloufar & Frédéric Batteux. (2015). Macro- and microvascular disease in systemic sclerosis. Vascular Pharmacology. 71. 16–23. 29 indexed citations

14.

Kavian, Niloufar, et al.. (2012). New Insights into the Mechanism of Notch Signalling in Fibrosis. The Open Rheumatology Journal. 6(1). 96–102. 49 indexed citations

15.

Marut, Wioleta, Niloufar Kavian, Amélie Servettaz, et al.. (2012). The Organotelluride Catalyst (PHTE)2NQ Prevents HOCl-Induced Systemic Sclerosis in Mouse. Journal of Investigative Dermatology. 132(4). 1125–1132. 15 indexed citations

16.

Kavian, Niloufar, Wioleta Marut, Amélie Servettaz, et al.. (2012). Reactive oxygen species–mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis. Arthritis & Rheumatism. 64(10). 3430–3440. 42 indexed citations

17.

Payet, Judith, Niloufar Kavian, Olivia Chandesris, et al.. (2012). Type I cryoglobulinemia in multiple myeloma, a rare entity: analysis of clinical and biological characteristics of seven cases and review of the literature. Leukemia & lymphoma. 54(4). 767–777. 30 indexed citations

18.

Hu, Honglin, Frédéric Batteux, Christiane Chéreau, et al.. (2011). Clopidogrel protects from cell apoptosis and oxidative damage in a mouse model of renal ischaemia–reperfusion injury. The Journal of Pathology. 225(2). 265–275. 31 indexed citations

19.

Servettaz, Amélie, Niloufar Kavian, Carole Nicco, et al.. (2010). Targeting the Cannabinoid Pathway Limits the Development of Fibrosis and Autoimmunity in a Mouse Model of Systemic Sclerosis. American Journal Of Pathology. 177(1). 187–196. 96 indexed citations

20.

Servettaz, Amélie, Claire Goulvestre, Niloufar Kavian, et al.. (2009). Selective Oxidation of DNA Topoisomerase 1 Induces Systemic Sclerosis in the Mouse. The Journal of Immunology. 182(9). 5855–5864. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact